“We want to make sure we’re talking to our members where and how they want to be spoken to.” That was something Sam’s Club VP health and family care Jason Reiser said to me for the special report we did on the company that appeared on the cover of our April 2 issue.
A guest column in the March 12 issue of DSN, “Let me tell you what PBMs do,” by Republican Utah State Rep. Evan Vickers, really set off a firestorm of debate on DrugStoreNews.com and on DSN’s social media sites.
“How does that help me sell more cases, pallets and truckloads?” That’s a question I have been asked repeatedly, particularly as the world of retail pharmacy has evolved to play a larger role in health care. With that, the business that we cover in Drug Store News has become incredibly more complicated.
According to IMS VP industry relations Doug Long, who spoke Feb. 6 at the National Association of Chain Drug Stores Regional Chain Meeting on current trends and forecasts for the U.S. pharmaceutical market, specialty pharmacy dollars are growing more than 10% on a 12-month moving annual total basis.
“Just 1-in-4 consumers expect their financial position to improve in the coming year.” That’s the way SymphonyIRI Group saw it in its recently released report “The Downturn Shopper: Buckled in for a wild and crazy ride.”
Somewhere along the road back from Boston, DSN publisher Wayne Bennett and I looked at each other and realized that the previous 24 hours or so had been some of the most productive time we had enjoyed at a trade show in quite a while.
“[Charlie] never wanted the spotlight,” long-time friend and colleague Al Kraus noted in an online post, recalling a conversation with Charlie Bowlus over a drink one night in 1994, at the end of the very first ECRM show.